Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−10.69 USD
−4.00 M USD
0.00 USD
2.60 M
About TNF Pharmaceuticals, Inc.
TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company that engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in Baltimore, MD.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of TNFA is 1.34 USD — it has decreased by −0.84% in the past 24 hours. Watch TNF Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange TNF Pharmaceuticals, Inc. stocks are traded under the ticker TNFA.
TNFA stock has fallen by −6.23% compared to the previous week, the month change is a −7.59% fall, over the last year TNF Pharmaceuticals, Inc. has showed a −99.57% decrease.
TNFA reached its all-time high on Jan 23, 2014 with the price of 756,449,280.00 USD, and its all-time low was 1.16 USD and was reached on Sep 18, 2024. View more price dynamics on TNFA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TNFA stock is 11.67% volatile and has beta coefficient of 0.10. Track TNF Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is TNF Pharmaceuticals, Inc. there?
Today TNF Pharmaceuticals, Inc. has the market capitalization of 3.69 M, it has decreased by −18.15% over the last week.
Yes, you can track TNF Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
TNF Pharmaceuticals, Inc. is going to release the next earnings report on Nov 14, 2024. Keep track of upcoming events with our Earnings Calendar.
TNFA net income for the last quarter is −9.57 M USD, while the quarter before that showed −9.80 M USD of net income which accounts for 2.39% change. Track more TNF Pharmaceuticals, Inc. financial stats to get the full picture.
No, TNFA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 6.00 employees. See our rating of the largest employees — is TNF Pharmaceuticals, Inc. on this list?
Like other stocks, TNFA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TNF Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TNF Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TNF Pharmaceuticals, Inc. stock shows the sell signal. See more of TNF Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.